ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
조류 인플루엔자 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 8.7%를 나타낼 것으로 예측되고 192억 3,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 인식 및 진단 확대, 팬데믹 대비를 위한 정부 정책, 연구 개발 투자 증가, 조류 인플루엔자 치료를 위한 효과적인 치료제 필요성, 그리고 광범위한 연구 개발 노력에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 새로운 치료법 개발, 미래 혁신 및 기술, 공동 연구 노력, 신규 사업 개발 및 투자 기회, 원격 의료 및 원격 상담 도입 등이 포함됩니다.
향후 5년간 8.7% 성장이라는 예측치는 해당 시장에 대한 이전 추정치 대비 0.6% 소폭 하락한 수치입니다. 이 하락은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 인상으로 프랑스와 인도에서 공급원으로부터 조달하는 뉴라미니다제 억제제와 조류 인플루엔자 검사 키트 비용이 상승하여 미국 팬데믹 대비에 부담이 될 가능성이 높습니다. 이는 발병 대응 비용을 악화시키고 항바이러스제 비축량을 제한할 것입니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과가 더 광범위하게 나타날 것입니다.
향후 조류 인플루엔자 치료 시장 확대는 인식 제고와 진단 기술 발전에 의해 촉진될 것으로 전망됩니다. 인식은 특정 질환을 인지하는 것을 의미하며, 진단은 그러한 인식을 바탕으로 구체적인 문제를 확인하는 과정입니다. 조류 인플루엔자 치료 수요는 공공 보건 보호, 잠재적 팬데믹 예방, 가금류 개체군의 막대한 경제적 손실 방지를 위한 시급한 필요성에서 비롯됩니다. 효과적인 조류 인플루엔자 치료를 위해서는 인식과 조기 진단이 필수적이며, 이를 통해 신속한 개입과 확산 방지가 가능해집니다. 예를 들어, 스위스에 본부를 둔 정부간 기관인 세계보건기구(WHO)는 2024년 4월 HPAI A(H5N1) 바이러스에 감염된 것으로 보이는 동물에 노출된 미국 내 8,000명 이상이 2022년 2월 9일부터 2024년 3월 29일까지 액티브 서베이런스 하에 있습니다. 따라서 의식 증가와 진단은 조류 인플루엔자 치료 시장의 성장을 이끌고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 조류 인플루엔자 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 조류 인플루엔자 치료 시장 : 성장률 분석
세계의 조류 인플루엔자 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 조류 인플루엔자 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 조류 인플루엔자 치료 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 조류 인플루엔자 치료 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
항생제
백신
항바이러스제
면역글로불린
세계의 조류 인플루엔자 치료 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
온라인 약국
오프라인 약국
세계의 조류 인플루엔자 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
시설 보건 센터
클리닉
세계의 조류 인플루엔자 치료 시장, 항생제 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
광역 스펙트럼 항생제
테트라사이클린계 항생제
페니실린계 항생제
마크로라이드계 항생제
세팔로스포린
항균 펩타이드
세계의 조류 인플루엔자 치료 시장, 백신 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
불활성화 백신
생약독화 백신
재조합 백신
서브 유닛 백신
DNA 백신
2가 백신 및 다가 백신
세계의 조류 인플루엔자 치료 시장, 항바이러스제 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
뉴라미니다제 억제제(오셀타미비르, 자나미비르)
M2 이온 채널 억제제(아만타딘)
폴리머라제 억제제
프로테아제 억제제
항바이러스 병용요법
세계의 조류 인플루엔자 치료 시장, 면역글로불린 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
인간 면역글로불린(Ivig)
단일클론항체
고면역 혈청
다가 면역글로불린
조류 인플루엔자 특이적 면역글로불린
제7장 지역별 및 국가별 분석
세계의 조류 인플루엔자 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 조류 인플루엔자 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
조류 인플루엔자 치료 시장 : 경쟁 구도
조류 인플루엔자 치료 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
AstraZeneca Plc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Novartis AG
GlaxoSmithKline Plc
Gilead Sciences Inc.
Baxter International Inc.
CSL Limited
Moderna Inc.
Cipla Ltd.
Shionogi & Co. Ltd.
Novavax Inc.
Seqirus Pty Ltd.
Sinovac Biotech Ltd.
Emergent BioSolutions Inc.
Dynavax Technologies Corporation
CureVac AG
Valneva SE
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
조류 인플루엔자 치료 시장(2029년) : 새로운 기회를 제공하는 국가
조류 인플루엔자 치료 시장(2029년) : 새로운 기회를 제공하는 부문
조류 인플루엔자 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Avian flu treatment involves medical approaches and strategies aimed at managing and easing symptoms of avian influenza, commonly known as bird flu, in infected individuals. Avian influenza is caused by viruses that primarily affect birds, though certain strains such as H5N1 and H7N9 can also infect humans, leading to severe illness or even death in some cases.
The primary treatments for avian flu include antibiotics, vaccines, antiviral agents, and immunoglobulins. Antibiotics are medications designed to combat bacterial infections. These treatments are accessible through both online and offline pharmacies and are utilized by various end-users such as hospitals, institutional health centers, and clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The avian flu treatment market research report is one of a series of new reports from The Business Research Company that provides avian flu treatment market statistics, including avian flu treatment industry global market size, regional shares, competitors with a avian flu treatment market share, detailed avian flu treatment market segments, market trends and opportunities, and any further data you may need to thrive in the avian flu treatment industry. This avian flu treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The avian flu treatment market size has grown strongly in recent years. It will grow from $12.59 billion in 2024 to $13.77 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increased demand for avian flu treatment, rise in measures to prevent the spread of bird flu, increased availability of treatment options, increased investment for healthcare infrastructure, and increased demand for poultry for consumption.
The avian flu treatment market size is expected to see strong growth in the next few years. It will grow to $19.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growing awareness and diagnosis, government initiatives for pandemic preparedness, rising research and development investments, the need for effective therapeutics against avian influenza, and extensive research and development efforts. Major trends in the forecast period include the development of novel therapeutic approaches, future innovation and technologies, collaborative research efforts, new business development, and investment opportunities, and telemedicine and remote consultation implementation.
The forecast of 8.7% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. pandemic preparedness by driving up the cost of neuraminidase inhibitors and avian influenza test kits sourced from France and India, exacerbating outbreak response costs and limiting antiviral stockpiles. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
Growing awareness and improved diagnosis are anticipated to drive the expansion of the avian flu treatment market in the future. Awareness involves recognizing a condition, while diagnosis identifies a specific issue based on that awareness. The demand for avian flu treatment stems from the urgent need to protect public health, prevent potential pandemics, and shield poultry populations from substantial economic losses. Awareness and early diagnosis are vital for effective avian flu treatment, enabling prompt intervention and containment to prevent the disease from spreading. For instance, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in April 2024 that over 8,000 people in the US were under active surveillance from February 9, 2022, to March 29, 2024, after exposure to animals believed to be infected with the HPAI A (H5N1) virus. Thus, increasing awareness and diagnosis are driving the growth of the avian flu treatment market.
Leading companies in the avian flu treatment market are emphasizing partnerships to improve efficacy and accelerate the development of new treatments. These partnerships involve collaborations between pharmaceutical companies, research institutions, and government agencies to pool resources, share expertise, and conduct innovative clinical trials. For example, in April 2024, CureVac N.V., a biotechnology company based in Germany, partnered with GSK plc, a UK-based pharmaceutical company, to develop an investigational influenza A (H5N1) pre-pandemic vaccine candidate. This collaboration aims to address the potential future pandemic threat posed by the H5N1 avian influenza virus by evaluating the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which uses CureVac's proprietary second-generation mRNA technology. The combined Phase 1/2 study will assess the vaccine candidate's safety and effectiveness in healthy adults aged 18 to 64 and older adults aged 65 to 85.
In December 2022, Hester Biosciences Ltd., an Indian animal and poultry vaccine manufacturing company, acquired technology from the Indian Council of Agricultural Research and the National Institute of High-Security Animal Diseases (ICAR-NIHSAD) for an undisclosed amount. This acquisition aims to develop an inactivated H9N2 avian influenza vaccine for poultry, providing a solution to the significant economic losses experienced by Indian poultry farmers due to periodic outbreaks of the disease. The Indian Council of Agricultural Research and the National Institute of High-Security Animal Diseases (ICAR-NIHSAD) is an India-based research institute that offers technology for avian flu vaccines and diagnostic tests for avian influenza.
Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Gilead Sciences Inc., Baxter International Inc., CSL Limited, Moderna Inc., Cipla Ltd., Shionogi & Co. Ltd., Novavax Inc., Seqirus Pty Ltd., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, CureVac AG, Valneva SE, BioCryst Pharmaceuticals Inc., Siga Technologies Inc., Aridis Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Biolyse Pharma
North America was the largest region in the avian flu treatment market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the avian flu treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The avian flu treatment market consists of sales of antiviral medications, respiratory support equipment, and intravenous fluids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Avian Flu Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on avian flu treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for avian flu treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The avian flu treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Antibiotics; Vaccines; Antiviral Agents; Immunoglobulins
2) By Distribution Channel: Online Pharmacies; Offline Pharmacies
3) By End User: Hospital; Institutional Health Centers; Clinics
2) By Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Subunit Vaccines; Dna Vaccines; Bivalent And Multivalent Vaccines
3) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir); M2 Ion Channel Inhibitors (Amantadine); Polymerase Inhibitors; Protease Inhibitors; Antiviral Combination Therapies
4) By Immunoglobulins: Human Immunoglobulin (Ivig); Monoclonal Antibodies; Hyperimmune Serum; Polyvalent Immunoglobulins; Avian Flu-Specific Immunoglobulins
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Avian Flu Treatment Market Characteristics
3. Avian Flu Treatment Market Trends And Strategies
4. Avian Flu Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Avian Flu Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Avian Flu Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Avian Flu Treatment Market Growth Rate Analysis
5.4. Global Avian Flu Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Avian Flu Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Avian Flu Treatment Total Addressable Market (TAM)
6. Avian Flu Treatment Market Segmentation
6.1. Global Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibiotics
Vaccines
Antiviral Agents
Immunoglobulins
6.2. Global Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online Pharmacies
Offline Pharmacies
6.3. Global Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Institutional Health Centers
Clinics
6.4. Global Avian Flu Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Broad-Spectrum Antibiotics
Tetracycline Antibiotics
Penicillin-Based Antibiotics
Macrolide Antibiotics
Cephalosporins
Antimicrobial Peptides
6.5. Global Avian Flu Treatment Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Subunit Vaccines
Dna Vaccines
Bivalent And Multivalent Vaccines
6.6. Global Avian Flu Treatment Market, Sub-Segmentation Of Antiviral Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neuraminidase Inhibitors (Oseltamivir, Zanamivir)
M2 Ion Channel Inhibitors (Amantadine)
Polymerase Inhibitors
Protease Inhibitors
Antiviral Combination Therapies
6.7. Global Avian Flu Treatment Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Immunoglobulin (Ivig)
Monoclonal Antibodies
Hyperimmune Serum
Polyvalent Immunoglobulins
Avian Flu-Specific Immunoglobulins
7. Avian Flu Treatment Market Regional And Country Analysis
7.1. Global Avian Flu Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Avian Flu Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
